Jounce Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2016 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Jounce Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2016 to Q4 2022.
  • Jounce Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2022 was 51.7M shares, a 3.5% increase year-over-year.
  • Jounce Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 51.7M shares, a 3.5% increase from 2021.
  • Jounce Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 49.9M shares, a 40.9% increase from 2020.
  • Jounce Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 35.4M shares, a 3.3% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 51.7M +1.75M +3.5% Oct 1, 2022 Dec 31, 2022 10-K/A 2023-04-28
Q3 2022 51.7M +462K +0.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 51.7M +466K +0.91% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 51.6M +5.68M +12.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 49.9M Oct 1, 2021 Dec 31, 2021 10-K/A 2023-04-28
Q3 2021 51.2M +17.1M +50% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 51.2M +17.2M +50.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 46M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 34.2M +18K +0.05% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 34.1M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q3 2019 34.1M +1.5M +4.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q3 2018 32.6M +459K +1.43% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q3 2017 32.2M +27.4M +577% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-13
Q3 2016 4.75M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.